Surveillance of Transmitted HIV-1 Drug Resistance in Drug-Naive and Newly Diagnosed Patients

The partnership assessed the prevalence of transmitted HIV‐1 drug resistance (TDR) in the chosen study sites and identified the most prevalent types of drug resistance mutations. They also assessed the potential to scale up of the HIV‐1 genotypic drug resistance test in Cameroon. Finally, they identified the major transmission routes of HIV‐1 and HIV‐1 drug resistance mutations in the study sites.
Read More